India remains on the US Trade Representative’s priority watch list for intellectual property concerns, citing inconsistent progress and long-standing issues with its Patents Act. The report highlights worries over data protection for pharma and agri-chemical products, alongside high customs duties on IP-intensive goods. Weak enforcement of copyrights and trademarks also remain key issues.